Canaccord Initiates NewLink Genetics at Buy

Loading...
Loading...
Canaccord has initiated coverage on NewLink Genetics
NLNK
with a Buy rating and $11 price target.
Posted In: Price TargetInitiationPre-Market OutlookAnalyst RatingsCanaccord
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...